Zacks Research Has Optimistic Outlook of SBC Q2 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Analysts at Zacks Research increased their Q2 2026 earnings per share estimates for shares of SBC Medical Group in a note issued to investors on Tuesday, May 19th. Zacks Research analyst M. Marin now forecasts that the company will post earnings of $0.13 per share for the quarter, up from their prior forecast of $0.12. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.45 per share.

SBC Medical Group (NASDAQ:SBC) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. The firm had revenue of $43.06 million during the quarter, compared to the consensus estimate of $41.66 million. SBC Medical Group had a return on equity of 15.90% and a net margin of 24.09%.

SBC has been the subject of a number of other research reports. BTIG Research assumed coverage on SBC Medical Group in a research report on Friday, March 6th. They set a “buy” rating and a $8.00 price target for the company. Wall Street Zen upgraded SBC Medical Group to a “hold” rating in a research report on Saturday, May 9th. Finally, Weiss Ratings upgraded SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

SBC Medical Group Stock Performance

Shares of SBC opened at $3.23 on Thursday. The company has a market cap of $331.32 million, a PE ratio of 8.28 and a beta of 0.61. The company has a current ratio of 3.82, a quick ratio of 3.78 and a debt-to-equity ratio of 0.12. The stock has a 50-day moving average price of $3.71 and a 200-day moving average price of $3.92. SBC Medical Group has a 12-month low of $2.78 and a 12-month high of $5.75.

Institutional Trading of SBC Medical Group

A number of hedge funds have recently bought and sold shares of the company. Wells Fargo & Company MN lifted its position in SBC Medical Group by 195.1% in the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock worth $54,000 after buying an additional 8,348 shares during the last quarter. Russell Investments Group Ltd. lifted its position in SBC Medical Group by 292.0% in the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after buying an additional 8,771 shares during the last quarter. Barclays PLC lifted its position in SBC Medical Group by 123.7% in the fourth quarter. Barclays PLC now owns 17,779 shares of the company’s stock valued at $77,000 after purchasing an additional 9,831 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in SBC Medical Group in the first quarter valued at approximately $43,000. Finally, Goldman Sachs Group Inc. bought a new stake in SBC Medical Group in the fourth quarter valued at approximately $49,000. Institutional investors own 60.82% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Yoshiyuki Aikawa sold 465,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $3.02, for a total value of $1,404,300.00. Following the completion of the sale, the chief executive officer owned 78,839,460 shares in the company, valued at $238,095,169.20. The trade was a 0.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In the last ninety days, insiders sold 7,987,900 shares of company stock valued at $20,142,848. Insiders own 89.47% of the company’s stock.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.